These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6125524)

  • 1. [Determination of talinolol in human plasma by high-performance liquid chromatography (author's transl)].
    Pötter H; Hülm M; Richter K
    J Chromatogr; 1982 May; 241(1):189-92. PubMed ID: 6125524
    [No Abstract]   [Full Text] [Related]  

  • 2. [A quick, simple HPLC method for determination of talinolol in serum].
    Oertel R; Richter K; Trausch B; Gramatté T
    Pharmazie; 1994 Apr; 49(4):291-2. PubMed ID: 7910972
    [No Abstract]   [Full Text] [Related]  

  • 3. Validated HPLC method for quantitative determination of talinolol in rat plasma and application to a preclinical pharmacokinetic study.
    Pathak SM; Musmade PB; Bhat KM; Udupa N
    Bioanalysis; 2010 Jan; 2(1):95-104. PubMed ID: 21083123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of xamoterol in human plasma by high-performance liquid chromatography with electrochemical detection.
    Davis PC
    J Chromatogr; 1987 Jun; 417(1):233-5. PubMed ID: 2887582
    [No Abstract]   [Full Text] [Related]  

  • 5. Elucidation of the structure of talinolol metabolites in man. Determination of talinolol and hydroxylated talinolol metabolites in urine and analysis of talinolol in serum.
    Oertel R; Richter K; Trausch B; Berndt A; Gramatté T; Kirch W
    J Chromatogr B Biomed Appl; 1994 Oct; 660(2):353-63. PubMed ID: 7866526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of betaxolol in plasma by high-performance liquid chromatography with fluorescence detection.
    Canal M; Flouvat B
    J Chromatogr; 1985 Jul; 342(1):212-5. PubMed ID: 2864353
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of carboxybupranolol, the major metabolite of bupranolol, in human plasma by high-performance liquid chromatography.
    Walmsley LM; Brodie RR; Chasseaud LF
    J Chromatogr; 1984 Nov; 311(1):227-33. PubMed ID: 6151568
    [No Abstract]   [Full Text] [Related]  

  • 8. High-performance liquid chromatographic assay for determination of a new beta-blocking agent FM 24.
    Lefebvre MA; Julian B; Fourtillan JB
    J Chromatogr; 1982 Jun; 230(1):199-202. PubMed ID: 6125522
    [No Abstract]   [Full Text] [Related]  

  • 9. High-performance liquid chromatographic method for the determination of carazolol in serum or plasma of pigs.
    Kadir F; Zuidema J
    J Chromatogr; 1990 May; 527(2):461-6. PubMed ID: 1974898
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of the beta-adrenoceptor blocking drug B24/76 in serum by high-performance liquid chromatography with fluorimetric detection after pre-column dansylation.
    Zschiesche M; Baumann A
    J Chromatogr; 1989 Mar; 488(2):482-6. PubMed ID: 2568366
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid and sensitive high-performance liquid chromatographic determination of bisoprolol in plasma and urine.
    Poirier JM; Perez M; Cheymol G; Jaillon P
    J Chromatogr; 1988 Apr; 426(2):431-7. PubMed ID: 2899087
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of esmolol in human blood by high-performance liquid chromatography and its application to pharmacokinetic studies.
    Achari R; Drissel D; Thomas D; Shin K; Look Z
    J Chromatogr; 1988 Feb; 424(2):430-4. PubMed ID: 2897375
    [No Abstract]   [Full Text] [Related]  

  • 13. Simple method for routine determination of betaxolol in blood and urine by automated high-performance liquid chromatography with fluorimetric detection.
    Caqueret H; Bianchetti G
    J Chromatogr; 1984 Nov; 311(1):199-205. PubMed ID: 6151567
    [No Abstract]   [Full Text] [Related]  

  • 14. Column liquid chromatographic measurement of betaxolol in plasma or serum.
    Bhamra RK; Ward AE; Holt DW
    J Chromatogr; 1987 Jun; 417(1):229-32. PubMed ID: 2887581
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of oral talinolol following a single dose and during steady state in patients with chronic renal failure and healthy volunteers.
    Krueger M; Achenbach H; Terhaag B; Haase H; Richter K; Oertel R; Preiss R
    Int J Clin Pharmacol Ther; 2001 Feb; 39(2):61-6. PubMed ID: 11270803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination by coupled high-performance liquid chromatography-gas chromatography of the beta-blocker levomoprolol in plasma following ophthalmic administration.
    Gianesello V; Brenn E; Figini G; Gazzaniga A
    J Chromatogr; 1989 Jul; 473(2):343-52. PubMed ID: 2570078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and sensitive column liquid chromatographic determination of sotalol in plasma.
    Poirier JM; Lebot M; Cheymol G
    J Chromatogr; 1989 Sep; 493(2):409-13. PubMed ID: 2573607
    [No Abstract]   [Full Text] [Related]  

  • 18. High-performance liquid chromatographic assay for the major blood metabolite of esmolol--an ultra short acting beta blocker.
    Stampfli HF; Lai CM; Yacobi A; Sum CY
    J Chromatogr; 1984 Jul; 309(1):203-8. PubMed ID: 6148350
    [No Abstract]   [Full Text] [Related]  

  • 19. [The protein binding of talinolol].
    Trausch B; Oertel R; Richter K; Gramatté T
    Pharmazie; 1995 Jan; 50(1):72. PubMed ID: 7886130
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct demonstration of small intestinal secretion and site-dependent absorption of the beta-blocker talinolol in humans.
    Gramatté T; Oertel R; Terhaag B; Kirch W
    Clin Pharmacol Ther; 1996 May; 59(5):541-9. PubMed ID: 8646825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.